Evidence map›Paper›PMID 27048566›Full record

ArticleScience signaling2016

Defining the stoichiometry of inositol 1,4,5-trisphosphate binding required to initiate Ca2+ release.

Kamil J Alzayady, Liwei Wang, Rahul Chandrasekhar, Larry E Wagner, Filip Van Petegem, David I Yule

Abstract read
In one paragraph

Article in Science signaling, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Pacemaking in the lymphatic system.The Journal of physiology · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. From IP3RPEP6 Inhibition of IPCellular and molecular life sciences : CMLS · 2025
    Review
  13. Article
  14. Article
  15. A pleiotropic recurrent dominantScience advances · 2024
    Article
  16. Article
  17. Agonist-Induced CaCells · 2024
    Article
  18. Review
  19. Article
  20. Review

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kamil J AlzayadyDepartment of Pharmacology and Physiology, University of Rochester, Rochester, NY 14642, USA.
Liwei WangDepartment of Pharmacology and Physiology, University of Rochester, Rochester, NY 14642, USA.
Rahul ChandrasekharDepartment of Pharmacology and Physiology, University of Rochester, Rochester, NY 14642, USA.
Larry E WagnerDepartment of Pharmacology and Physiology, University of Rochester, Rochester, NY 14642, USA.
Filip Van PetegemDepartment of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.
David I YuleDepartment of Pharmacology and Physiology, University of Rochester, Rochester, NY 14642, USA. david_yule@urmc.rochester.edu.

Funding

[Ca2+]i and Secretory Dynamics in Parotid Acinar CellsR01DE014756 · NIDCR · UNIVERSITY OF ROCHESTER · PI David I Yule · 2002 to 2026
$9.9M
An experimental/computational approach for understanding salivary fluid secretionR01DE019245 · NIDCR · UNIVERSITY OF ROCHESTER · PI David I Yule · 2008 to 2026
$9.7M
NIDCR NIH HHS DE019245NIDCR NIH HHS R01 DE014756NIDCR NIH HHS R01 DE019245
6 · The paper itself

Abstract

Inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) are tetrameric intracellular Ca(2+)-release channels with each subunit containing a binding site for IP3in the amino terminus. We provide evidence that four IP3molecules are required to activate the channel under diverse conditions. Comparing the concentration-response relationship for binding and Ca(2+)release suggested that IP3Rs are maximally occupied by IP3before substantial Ca(2+)release occurs. We showed that ligand binding-deficient subunits acted in a dominant-negative manner when coexpressed with wild-type monomers in the chicken immune cell line DT40-3KO, which lacks all three genes encoding IP3R subunits, and confirmed the same effect in an IP3R-null human cell line (HEK-3KO) generated by CRISPR/Cas9 technology. Using dimeric and tetrameric concatenated IP3Rs with increasing numbers of binding-deficient subunits, we addressed the obligate ligand stoichiometry. The concatenated IP3Rs with four ligand-binding sites exhibited Ca(2+)release and electrophysiological properties of native IP3Rs. However, IP3failed to activate IP3Rs assembled from concatenated dimers consisting of one binding-competent and one binding-deficient mutant subunit. Similarly, IP3Rs containing two monomers of IP3R2short, an IP3binding-deficient splice variant, were nonfunctional. Concatenated tetramers containing only three binding-competent ligand-binding sites were nonfunctional under a wide range of activating conditions. These data provide definitive evidence that IP3-induced Ca(2+)release only occurs when each IP3R monomer within the tetramer is occupied by IP3, thereby ensuring fidelity of Ca(2+)release.

Indexed as

Protein DomainsAnimalsBinding SitesCalciumCalcium SignalingCell LineCRISPR-Cas SystemsHEK293 CellsHumansInositol 1,4,5-TrisphosphateInositol 1,4,5-Trisphosphate ReceptorsModels, MolecularMolecular StructureMutationProtein BindingProtein MultimerizationCalciumInositol 1,4,5-TrisphosphateInositol 1,4,5-Trisphosphate ReceptorsITPR1 protein, humanProtein Subunits

Identifiers

PMID27048566
PMCPMC4850551

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.